1-20 of 36
Rajiv Agarwal
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Overall Adverse Event Profile of Vadadustat versus Darbepoetin Alfa for the Treatment of Anemia Associated with Chronic Kidney Disease in Phase 3 Trials

Subject Area:
Nephrology
Rajiv Agarwal, Sanjeev Anand, Kai-Uwe Eckardt, Wenli Luo, Patrick S. Parfrey, Mark J. Sarnak, Christine M. Solinsky, Dennis L. Vargo, Wolfgang C. Winkelmayer, Glenn M. Chertow
Journal: American Journal of Nephrology
Am J Nephrol (2022) 53 (10): 701–710.
https://doi.org/10.1159/000528443
Published Online: 31 January 2023
View articletitled, Overall Adverse Event Profile of Vadadustat versus Darbepoetin Alfa for the Treatment of Anemia Associated with Chronic Kidney Disease in Phase 3 Trials
Open the PDF for Overall Adverse Event Profile of Vadadustat versus Darbepoetin Alfa for the Treatment of Anemia Associated with Chronic Kidney Disease in Phase 3 Trials in another window
Journal Articles

The Therapeutic Evaluation of Steroids in IgA Nephropathy Global (TESTING) Study: Trial Design and Baseline Characteristics

Subject Area:
Nephrology
Muh Geot Wong, Jicheng Lv, Michelle A. Hladunewich, Vivekanand Jha, Lai Seong Hooi, Helen Monaghan, Minghui Zhao, Sean Barbour, Heather N. Reich, Daniel Cattran, Richard Glassock, Adeera Levin, Meg J. Jardine, David C. Wheeler, Mark Woodward, Laurent Billot, Tak Mao Chan, Zhi-Hong Liu, David W. Johnson, Alan Cass, John Feehally, Jürgen Floege, Giuseppe Remuzzi, Yangfeng Wu, Rajiv Agarwal, Hong Zhang, Vlado Perkovic, for the TESTING Study Group
Journal: American Journal of Nephrology
Am J Nephrol (2021) 52 (10-11): 827–836.
https://doi.org/10.1159/000519812
Published Online: 03 November 2021
View articletitled, The Therapeutic Evaluation of Steroids in IgA Nephropathy Global (TESTING) Study: Trial Design and Baseline Characteristics
Open the PDF for The Therapeutic Evaluation of Steroids in IgA Nephropathy Global (TESTING) Study: Trial Design and Baseline Characteristics in another window
Journal Articles

Design and Baseline Characteristics of the Chlorthalidone in Chronic Kidney Disease (CLICK) Trial

Subject Area:
Nephrology
Rajiv Agarwal, Andrew E. Cramer, Mary Balmes-Fenwick, Arjun D. Sinha, Fangqian Ouyang, Wanzhu Tu
Journal: American Journal of Nephrology
Am J Nephrol (2020) 51 (7): 542–552.
https://doi.org/10.1159/000508700
Published Online: 14 July 2020
View articletitled, Design and Baseline Characteristics of the Chlorthalidone in Chronic Kidney Disease (CLICK) Trial
Open the PDF for Design and Baseline Characteristics of the Chlorthalidone in Chronic Kidney Disease (CLICK) Trial in another window
Journal Articles

Design and Baseline Characteristics of the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease Trial

Subject Area:
Nephrology
Luis M. Ruilope, Rajiv Agarwal, Stefan D. Anker, George L. Bakris, Gerasimos Filippatos, Christina Nowack, Peter Kolkhof, Amer Joseph, Nicole Mentenich, Bertram Pitt, FIGARO-DKD study investigators
Journal: American Journal of Nephrology
Am J Nephrol (2019) 50 (5): 345–356.
https://doi.org/10.1159/000503712
Published Online: 30 October 2019
View articletitled, Design and Baseline Characteristics of the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease Trial
Open the PDF for Design and Baseline Characteristics of the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease Trial in another window
Journal Articles

Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial

Subject Area:
Topic Article Package: Best of Nephrology 2020 , Nephrology
George L. Bakris, Rajiv Agarwal, Stefan D. Anker, Bertram Pitt, Luis M. Ruilope, Christina Nowack, Peter Kolkhof, Anna C. Ferreira, Patrick Schloemer, Gerasimos Filippatos, on behalf of the FIDELIO-DKD study investigators
Journal: American Journal of Nephrology
Am J Nephrol (2019) 50 (5): 333–344.
https://doi.org/10.1159/000503713
Published Online: 25 October 2019
View articletitled, Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial
Open the PDF for Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial in another window
Journal Articles

Systolic Blood Pressure Intervention Trial and Statins, a Story of Statistical Interaction

Subject Area:
Nephrology
Wanzhu Tu, Rajiv Agarwal
Journal: American Journal of Nephrology
Am J Nephrol (2019) 49 (4): 294–296.
https://doi.org/10.1159/000499189
Published Online: 27 March 2019
View articletitled, Systolic Blood Pressure Intervention Trial and Statins, a Story of Statistical Interaction
Open the PDF for Systolic Blood Pressure Intervention Trial and Statins, a Story of Statistical Interaction in another window
Journal Articles

Meet the Twins: Intradialytic and Interdialytic Hypertension

Subject Area:
Nephrology
Panagiotis I. Georgianos, Rajiv Agarwal
Journal: American Journal of Nephrology
Am J Nephrol (2018) 48 (4): 292–294.
https://doi.org/10.1159/000493990
Published Online: 22 October 2018
View articletitled, Meet the Twins: Intradialytic and Interdialytic Hypertension
Open the PDF for Meet the Twins: Intradialytic and Interdialytic Hypertension in another window
Journal Articles

Patiromer to Enable Spironolactone Use in the Treatment of Patients with Resistant Hypertension and Chronic Kidney Disease: Rationale and Design of the AMBER Study

Subject Area:
Nephrology
Rajiv Agarwal, Patrick Rossignol, Dahlia Garza, Martha R. Mayo, Suzette Warren, Susan Arthur, Alain Romero, William B. White, Bryan Williams
Journal: American Journal of Nephrology
Am J Nephrol (2018) 48 (3): 172–180.
https://doi.org/10.1159/000492622
Published Online: 03 September 2018
View articletitled, Patiromer to Enable Spironolactone Use in the Treatment of Patients with Resistant Hypertension and Chronic Kidney Disease: Rationale and Design of the AMBER Study
Open the PDF for Patiromer to Enable Spironolactone Use in the Treatment of Patients with Resistant Hypertension and Chronic Kidney Disease: Rationale and Design of the AMBER Study in another window
Journal Articles

The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics

Subject Area:
Nephrology
Meg J. Jardine, Kenneth W. Mahaffey, Bruce Neal, Rajiv Agarwal, George L. Bakris, Barry M. Brenner, Scott Bull, Christopher P. Cannon, David M. Charytan, Dick de Zeeuw, Robert Edwards, Tom Greene, Hiddo J.L. Heerspink, Adeera Levin, Carol Pollock, David C. Wheeler, John Xie, Hong Zhang, Bernard Zinman, Mehul Desai, Vlado Perkovic, on behalf of the CREDENCE study investigators
Journal: American Journal of Nephrology
Am J Nephrol (2018) 46 (6): 462–472.
https://doi.org/10.1159/000484633
Published Online: 13 December 2017
View articletitled, The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics
Open the PDF for The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics in another window
Journal Articles

A Comparison of the Safety and Efficacy of HX575 (Epoetin Alfa Proposed Biosimilar) with Epoetin Alfa in Patients with End-Stage Renal Disease

Subject Area:
Nephrology
Matthew R. Weir, Pablo E. Pergola, Rajiv Agarwal, Jeffrey C. Fink, Nelson P. Kopyt, Ajay K. Singh, Jayant Kumar, Susanne Schmitt, Gregor Schaffar, Anita Rudy, Jim P. McKay, Radmila Kanceva
Journal: American Journal of Nephrology
Am J Nephrol (2017) 46 (5): 364–370.
https://doi.org/10.1159/000481736
Published Online: 30 October 2017
View articletitled, A Comparison of the Safety and Efficacy of HX575 (Epoetin Alfa Proposed Biosimilar) with Epoetin Alfa in Patients with End-Stage Renal Disease
Open the PDF for A Comparison of the Safety and Efficacy of HX575 (Epoetin Alfa Proposed Biosimilar) with Epoetin Alfa in Patients with End-Stage Renal Disease in another window
Journal Articles

Modification of Potassium-Mortality Relationship by Ethnicity and Race: Solving the Puzzle

Subject Area:
Nephrology
Rajiv Agarwal
Journal: American Journal of Nephrology
Am J Nephrol (2017) 45 (6): 552–554.
https://doi.org/10.1159/000476004
Published Online: 30 May 2017
View articletitled, Modification of Potassium-Mortality Relationship by Ethnicity and Race: Solving the Puzzle
Open the PDF for Modification of Potassium-Mortality Relationship by Ethnicity and Race: Solving the Puzzle in another window
Journal Articles

Patiromer Decreases Serum Potassium and Phosphate Levels in Patients on Hemodialysis

Subject Area:
Nephrology
David A. Bushinsky, Patrick Rossignol, David M. Spiegel, Wade W. Benton, Jinwei Yuan, Geoffrey A. Block, Christopher S. Wilcox, Rajiv Agarwal
Journal: American Journal of Nephrology
Am J Nephrol (2016) 44 (5): 404–410.
https://doi.org/10.1159/000451067
Published Online: 27 October 2016
View articletitled, Patiromer Decreases Serum Potassium and Phosphate Levels in Patients on Hemodialysis
Open the PDF for Patiromer Decreases Serum Potassium and Phosphate Levels in Patients on Hemodialysis in another window
Journal Articles

Adverse Effects of Conventional Thrice-Weekly Hemodialysis: Is It Time to Avoid 3-Day Interdialytic Intervals?

Subject Area:
Nephrology , Karger OLA
Panagiotis I. Georgianos, Pantelis A. Sarafidis, Arjun D. Sinha, Rajiv Agarwal
Journal: American Journal of Nephrology
Am J Nephrol (2015) 41 (4-5): 400–408.
https://doi.org/10.1159/000435842
Published Online: 27 June 2015
View articletitled, Adverse Effects of Conventional Thrice-Weekly Hemodialysis: Is It Time to Avoid 3-Day Interdialytic Intervals?
Open the PDF for Adverse Effects of Conventional Thrice-Weekly Hemodialysis: Is It Time to Avoid 3-Day Interdialytic Intervals? in another window
Journal Articles

Rationale, Design, and Baseline Characteristics of ARTS-DN: A Randomized Study to Assess the Safety and Efficacy of Finerenone in Patients with Type 2 Diabetes Mellitus and a Clinical Diagnosis of Diabetic Nephropathy

Subject Area:
Topic Article Package: Diabetes , Nephrology
Luis M. Ruilope, Rajiv Agarwal, Juliana C. Chan, Mark E. Cooper, Ron T. Gansevoort, Hermann Haller, Giuseppe Remuzzi, Peter Rossing, Roland E. Schmieder, Christina Nowack, Anna C. Ferreira, Alexander Pieper, Nina Kimmeskamp-Kirschbaum, George L. Bakris
Journal: American Journal of Nephrology
Am J Nephrol (2015) 40 (6): 572–581.
https://doi.org/10.1159/000371497
Published Online: 10 January 2015
View articletitled, Rationale, Design, and Baseline Characteristics of ARTS-DN: A Randomized Study to Assess the Safety and Efficacy of Finerenone in Patients with Type 2 Diabetes Mellitus and a Clinical Diagnosis of Diabetic Nephropathy
Open the PDF for Rationale, Design, and Baseline Characteristics of ARTS-DN: A Randomized Study to Assess the Safety and Efficacy of Finerenone in Patients with Type 2 Diabetes Mellitus and a Clinical Diagnosis of Diabetic Nephropathy in another window
Journal Articles

Chlorthalidone for Poorly Controlled Hypertension in Chronic Kidney Disease: An Interventional Pilot Study

Subject Area:
Nephrology , Karger OLA
Rajiv Agarwal, Arjun D. Sinha, Maria K. Pappas, Farah Ammous
Journal: American Journal of Nephrology
Am J Nephrol (2014) 39 (2): 171–182.
https://doi.org/10.1159/000358603
Published Online: 11 February 2014
View articletitled, Chlorthalidone for Poorly Controlled Hypertension in Chronic Kidney Disease: An Interventional Pilot Study
Open the PDF for Chlorthalidone for Poorly Controlled Hypertension in Chronic Kidney Disease: An Interventional Pilot Study in another window
Journal Articles

Renal Failure in Cirrhosis: Is It Time to Change the Diagnosis and Classification?

Subject Area:
Nephrology
Suthat Liangpunsakul, Rajiv Agarwal
Journal: American Journal of Nephrology
Am J Nephrol (2013) 38 (4): 342–344.
https://doi.org/10.1159/000355570
Published Online: 05 October 2013
View articletitled, Renal Failure in Cirrhosis: Is It Time to Change the Diagnosis and Classification?
Open the PDF for Renal Failure in Cirrhosis: Is It Time to Change the Diagnosis and Classification? in another window
Journal Articles

Volume Overload in Dialysis: The Elephant in the Room, No One Can See

Subject Area:
Nephrology
Rajiv Agarwal
Journal: American Journal of Nephrology
Am J Nephrol (2013) 38 (1): 75–77.
https://doi.org/10.1159/000353107
Published Online: 06 July 2013
View articletitled, Volume Overload in Dialysis: The Elephant in the Room, No One Can See
Open the PDF for Volume Overload in Dialysis: The Elephant in the Room, No One Can See in another window
Journal Articles

Rationale and Trial Design of Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: The Occurrence of Renal Events (BEACON)

Subject Area:
Topic Article Package: Diabetes , Nephrology
Dick de Zeeuw, Tadao Akizawa, Rajiv Agarwal, Paul Audhya, George L. Bakris, Melanie Chin, Melissa Krauth, Hiddo J. Lambers Heerspink, Colin J. Meyer, John J. McMurray, Hans-Henrik Parving, Pablo E. Pergola, Giuseppe Remuzzi, Robert D. Toto, Nosratola D. Vaziri, Christoph Wanner, David G. Warnock, Janet Wittes, Glenn M. Chertow
Journal: American Journal of Nephrology
Am J Nephrol (2013) 37 (3): 212–222.
https://doi.org/10.1159/000346948
Published Online: 28 February 2013
View articletitled, Rationale and Trial Design of Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: The Occurrence of Renal Events (BEACON)
Open the PDF for Rationale and Trial Design of Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: The Occurrence of Renal Events (BEACON) in another window
Journal Articles

Epidemiology of Interdialytic Ambulatory Hypertension and the Role of Volume Excess

Subject Area:
Nephrology
Rajiv Agarwal
Journal: American Journal of Nephrology
Am J Nephrol (2011) 34 (4): 381–390.
https://doi.org/10.1159/000331067
Published Online: 02 September 2011
View articletitled, Epidemiology of Interdialytic Ambulatory Hypertension and the Role of Volume Excess
Open the PDF for Epidemiology of Interdialytic Ambulatory Hypertension and the Role of Volume Excess in another window
Journal Articles

Relationship between Glycosylated Hemoglobin and Blood Glucose during Progression of Chronic Kidney Disease

Subject Area:
Topic Article Package: Diabetes , Nephrology
Rajiv Agarwal, Robert P. Light
Journal: American Journal of Nephrology
Am J Nephrol (2011) 34 (1): 32–41.
https://doi.org/10.1159/000328737
Published Online: 09 June 2011
View articletitled, Relationship between Glycosylated Hemoglobin and Blood Glucose during Progression of Chronic Kidney Disease
Open the PDF for Relationship between Glycosylated Hemoglobin and Blood Glucose during Progression of Chronic Kidney Disease in another window